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19th CardioVascular Summit: TCTAP 2014generation DES with long term outcomes. Our objective is to compare the efﬁcacy and
safety of the XIENCE V EES and the MULTI-LINK VISION cobalt chromium
stent (CCS) which has same platform in the setting of primary intervention for STEMI
patients.
Methods: Consecutive 338 patients with STEMI, who were treated with EES (162
patients) and CCS (176 patients). Within ten months angiographic follow-up results
and 2-year clinical follow-up outcomes were compared between 2 groups.
Results: The prevalence of diabetes and Chronic kidney disease were higher, the stent
length was longer (24.19.5 vs. 18.28.3, p<0.05), and late loss was smaller in EES
than in CCS group (0.250.24 vs. 0.550.33). However, the initial success rate was
similar between two groups. Follow-up data for 2-year, % binary restenosis (2.0 vs.
10.9%, p<0.05), TLR (2.0% vs. 9.7%, p<0.05), MI ( 0.7% vs.4.8%, p<0.05) and
stent thrombosis (0.7% vs. 4.2%, p<0.05) were signiﬁcantly higher in CCS than in
EES group.
Conclusion: EES implantation in patients with STEMI cases inhibited 2-year MACE
including TLR, MI and ST without increasing mortality compared with CCS
implantation.
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Background: Primary PCI in STEMI is the preferred treatment, but not a feasible
option for many and pharmacoinvasive therapy might be a practical solution in the
Indian context. The objective of this study is to assess the efﬁcacy of pharma-
coinvasive strategy in STEMI patients versus primary PCI.
Methods: This is an observational, multicenter study that prospectively enrolled 200
patients with STEMI. Patients who were ﬁbrinolysed (n¼45) formed arm ‘A’ and
underwent CAG within 3-24 hours with coronary intervention as appropriate. Arm ‘B’
consisted of patients who opted for primary PCI (n¼155). Primary endpoint was
composite of death, cardiogenic shock, reinfarction, repeat revascularization or
congestive heart failure up to 1 year.
Results: The IRA patency at angiogram was 82.2% in arm A and 22.6% in arm B
(‘p’ <0.001). PCI was performed in 73.3% Vs 100 % (‘p’<0.001), thrombus was
present in 26.7% Vs 63.2% (‘p’<0.001) in arms A & B respectively. Signiﬁcantly
more number of patients in arm A had TIMI 3 ﬂow in the culprit vessel at angio-
gram than arm B, 27.9% Vs 4.5% (‘p’ < 0.001). Failed ﬁbrinolysis occurred in
12.1%. Total ischemic time was 245 minutes (185-395) for arm A and 260 minutes
(185-390) for arm B. There was no difference in bleeding risk. Primary end
point occurred in 13.3% in arm A and in 9% in arm B, ‘p’¼ 0.40, (RR 0.64; 95% CI
0.24- 1.79).
Conclusion: Pharmacoinvasive strategy resulted in comparable outcomes as primary
PCI at 1 year. Larger RCTs are required to conﬁrm these ﬁndings.
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Background: During the last decades, as the treatment for acute myocardial infarction
(AMI) has been improved, in-hospital mortality of AMI has been decreased.
Accordingly, the purpose of this study was to ensure and reassess the importance of
Killip classiﬁcation in modern pharmaco-invasive treatment eracompared with other
common prognostic variables.
Methods: From January 2013 to July 2013, we analyzed information from 250 patients
with AMI in Mie CCU registry data. Mie CCU network was established for the early
pre-hospital care of patients with AMI and consecutive AMI patients was registered at
Mie CCU registry data. They were categorized to Killip 1, 2/3 (heart failure) and 4
(shock status). Multivariate cox proportional hazard models were developed to
determine the prognostic importance of killip classiﬁcation in comparison with other
variables. Primary end point of this study is deﬁned as all cause in-hospital mortality.
Results: Overall in-hospital mortality was 11.4%. Higher Killip classiﬁcation was
associated with higher in-hospital mortality (2.1% in Killip 1, 6.8% in 2/3, 45.9% in 4;
P<0.0001, See ﬁgure). According to the multivariate analysis, Killip classiﬁcation,
serum-creatinine and postrprocedural TIMI ﬂow were independent predictor for in-
hospital mortality. In addition, Killip classiﬁcation is the strongest independent pre-
dictor with hazard ratio of 7.3 compared to other factors.
Conclusion: Killip classiﬁcation is still powerful independent predictor for in-hospital
mortality. In comparison with the studies for the last several decades, in-hospital
mortality in patients with Killip 1 and 2/3 at modern treatment era was lower.S4 JACC Vol 63/12/Suppl S j April 22–25, 2014 jTCTAP A-012
The Protective Effect of Aspiration Thrombectomy on Side Branch Compromise
and Twelve Months Clinical Outcomes in AMI with Bifurcation Lesion
Undergoing Primary PCI
Ji Young Park, Jigyoung Park, Sungkee Rhy, Changsup Song
Eulji General Hospital, Seoul, Korea (Republic of)
Background: Bifurcation lesions (BF) remains a challenging lesion subset, often
associated with lower success rates. Side branch (SB) compromise in bifurcation
lesion is a major determinant of lower procedural success rates and adverse outcomes.
Aspiration thrombectomy (AT) prevent distal embolization in acute myocardial
infarction (AMI). The aim of this study is to evaluate the protective effect of AT on SB
compromise in BF lesions and twelve months clinical outcomes in AMI patients
undergoing primary percutaneous coronary intervention (PCI).
Methods: A total of 201 AMI patients with bifurcation lesion undergoing PCI were
analyzed between 2007 and 2011. The patients were divided into two groups ac-
cording to use of AT (AT group: n¼74, non AT group:n¼127).
We compared Thrombolysis In Myocardial Infarction (TIMI) of main and side
branch and 12 months clinical outcomes including mortality, reinfarction, target lesion
revascularization (TLR), and major adverse cardiac event (MACE) including mor-
tality, reinfarction, and TLR.
Results: Baseline clinical characteristics were similar between two groups. Angio-
graphic characteristics showed that LAD lesion was higher in non AT group (39.2%
vs 54.8%, p¼0.04) and RCA lesion was higher in AT group (45.9% vs 31.7%,
p¼0.050). Visible thrombus (94.6% vs 65.3%, p<0.001) and the use of GP IIb/IIIa
inhibitor (43.2% vs 27.6%, p¼0.030) was higher in AT group. PreTIMI was similar
between two groups. However, post TIMI 3 ﬂow was higher in AT group (94.4% vs
80.2%, p¼0.033). However, there were no difference of 12 months clinical outcomes
including mortality (5.4% vs 9.1%, p¼0.708), reinfarction (5.4% vs 12.1%, p¼0.324),
TLR (0.0% VS 3.0%, P¼535), and MACE (13.5% vs 28.8%, p¼0.093). Kaplan-
Meyer curve showed that the cumulative incidence of MACE was similar between two
groups (Log rank¼0.196)
Conclusion: In the present study, AT is related to post TIMI 3 ﬂow in AMI patients
with BF lesion undergoing primary PCI. However, cumulative incidence of MACE
was similar between two groups.TCTAP A-013
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Background: The presence of bundle branch block (BBB) has been associated with
poor clinical outcome in patients with acute myocardial infarction (MI). BBB,
particularly left BBB, in diabetes mellitus (DM) may signify advanced cardiovascularTCTAP Abstracts/ORAL/Acute Coronary Syndrome: STEMI, NSTE-ACS
